Rho-kinase inhibition improves erectile function in aging male Brown-Norway rats.
about
Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivityThe vitamin D receptor agonist elocalcitol upregulates L-type calcium channel activity in human and rat bladderY-27632 improves the erectile dysfunction with ageing in SD rats through adjusting the imbalance between nNo and the Rho-kinase pathwaysRho kinase-mediated local cold-induced cutaneous vasoconstriction is augmented in aged human skin.RhoA/Rho-kinase and vascular diseases: what is the link?Erectile function is improved in aged rats by PnTx2-6, a toxin from Phoneutria nigriventer spider venom.New approaches to the design and discovery of therapies to prevent erectile dysfunction.Molecular mechanisms of detrusor and corporal myocyte contraction: identifying targets for pharmacotherapy of bladder and erectile dysfunctionDiagnosis and treatment of sexual dysfunctions in late-onset hypogonadismUnderstanding and targeting the Rho kinase pathway in erectile dysfunction.Neurophysiological basis of penile erection.Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activationPDE5 inhibitors for LUTS.Efficacy of Cinnamomum cassia Blume. in age induced sexual dysfunction of ratsEmerging role for TNF-α in erectile dysfunction.The promise of inhibition of smooth muscle tone as a treatment for erectile dysfunction: where are we now?Modulation of soluble guanylate cyclase for the treatment of erectile dysfunction.Aging and sexual health: getting to the problem.Erectile properties of the Rho-kinase inhibitor SAR407899 in diabetic animals and human isolated corpora cavernosa.Association of nNOS and Rho-kinase with age-associated erectile dysfunction in Sprague-Dawley rats.Ageing causes cytoplasmic retention of MaxiK channels in rat corporal smooth muscle cells.Urodynamic effects of once-daily tadalafil in men with LUTS secondary to clinical BPH.The POTENT II randomised trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction.Chronic inhibition of nitric-oxide synthase induces hypertension and erectile dysfunction in the rat that is not reversed by sildenafil.Pravastatin improves the impaired nitric oxide-mediated neurogenic and endothelium-dependent relaxation of corpus cavernosum in aged rats.The effect of chronic partial bladder outlet obstruction on corpus cavernosum smooth muscle and Rho-kinase in rabbits.Additive effects of the Rho kinase inhibitor Y-27632 and vardenafil on relaxation of the corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure.
P2860
Q28264544-668A1861-622F-424B-A8EB-68E7F356EDF3Q28572726-4AF056CC-4A89-4E6D-A878-3A773F6EE51BQ28576020-521F0964-0403-4F27-9639-6EADC5FD0778Q33281441-526F78D6-330A-44A9-8E3C-D51D7808307BQ34378293-2D8DEDBE-A37C-42E3-A902-B6A00E025FA9Q34641766-ACB1BAD7-F28C-4AE1-968D-E094620E6BC0Q34664336-2D9D59B3-33CC-430F-AFD9-6480EBA5FEF7Q35545755-1F4FFCDD-5A36-4664-9810-C998A8F2E6AFQ35624509-523548B1-D630-434D-8230-FCEEE8DF7FFBQ36416633-651AD695-94F7-4813-9BC5-17B95D8866EBQ36824270-40342F54-61DF-4A08-A291-185CC0867C9BQ37252197-0822927D-B660-4FF5-80B3-BFAC0CC835B0Q37581408-3EEB3B3C-D336-4F74-8DE2-C21C8453DC3CQ37594796-8DC74B0D-FA2B-4633-9880-D674B0652962Q37719686-FA3885CA-9609-41D2-B271-A37BB8BD91A9Q37942765-E85B63ED-FBC9-465A-89E5-376DB5B15C22Q38118626-7055C285-935D-43D9-8F45-DF7BB825AE3EQ38738470-0430BACE-1B5A-4CA7-B064-C9E85D0B992BQ41873056-7B606009-6081-4C86-8AB2-6CAEA219C71BQ42290624-9035DB4B-D6A6-4CD7-9BB9-26E9BD4CA7DFQ42628321-52C4B0FA-91DA-41A8-AFBE-7B546DA6987EQ43060743-182DA582-D858-4B4E-BAF8-E6F06000DBC4Q43067802-436898E3-CC5C-4555-9888-15804A42D86BQ43225321-68FA2176-8E05-4849-A941-740ECD12B788Q43690803-B7336869-7A09-49A6-940D-26C2DBDA13F6Q46541937-6E3B1A3E-4154-4909-8222-B1D46E84B675Q51373209-04D3A4D5-F4A9-4739-985E-69D2B4D22255
P2860
Rho-kinase inhibition improves erectile function in aging male Brown-Norway rats.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Rho-kinase inhibition improves erectile function in aging male Brown-Norway rats.
@en
Rho-kinase inhibition improves erectile function in aging male Brown-Norway rats.
@nl
type
label
Rho-kinase inhibition improves erectile function in aging male Brown-Norway rats.
@en
Rho-kinase inhibition improves erectile function in aging male Brown-Norway rats.
@nl
prefLabel
Rho-kinase inhibition improves erectile function in aging male Brown-Norway rats.
@en
Rho-kinase inhibition improves erectile function in aging male Brown-Norway rats.
@nl
P2093
P2860
P1433
P1476
Rho-kinase inhibition improves erectile function in aging male Brown-Norway rats.
@en
P2093
Angelo Baquir
Mahadevan Rajasekaran
Nathan Wilkes
Steven White
P2860
P304
P356
10.1002/J.1939-4640.2005.TB01084.X
P577
2005-03-01T00:00:00Z